List of Epiduo drug patents
Epiduo is owned by Galderma Labs Lp.
Epiduo contains Adapalene; Benzoyl Peroxide.
Epiduo has a total of 10 drug patents out of which 4 drug patents have expired.
Expired drug patents of Epiduo are:
- US8105618
- US8241649
- US8936800
- US8809305
Epiduo was authorised for market use on 08 December, 2008.
Epiduo is available in gel;topical dosage forms.
Epiduo can be used as treatment of acne.
The generics of Epiduo are possible to be released after 18 July, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8105618 | GALDERMA LABS LP | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec, 2022
(5 months ago) | |
| US8241649 | GALDERMA LABS LP | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec, 2022
(5 months ago) | |
| US8936800 | GALDERMA LABS LP | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(5 months ago) | |
| US8809305 | GALDERMA LABS LP | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec, 2022
(5 months ago) | |
| US7964202 | GALDERMA LABS LP | Method for treatment of common acne |
Sep, 2024
(1 year, 2 months from now) | |
| US7820186 | GALDERMA LABS LP | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Nov, 2025
(2 years from now) | |
| US8445543 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(4 years from now) | |
| US8071644 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(4 years from now) | |
| US8129362 | GALDERMA LABS LP | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(4 years from now) | |
| US8080537 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(4 years from now) | |
Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient
Market Authorisation Date: 08 December, 2008
Treatment: Treatment of acne
Dosage: GEL;TOPICAL
EPIDUO family patents
25
United States
6
Japan
6
European Union
5
Russia
4
Australia
4
Korea, Republic of
4
Denmark
4
Spain
4
Cyprus
4
Portugal
4
Poland
4
Slovenia
3
Canada
3
France
3
Argentina
3
Hungary
2
Germany
2
Mexico
2
Brazil
2
China
1
Colombia
1
Croatia
1
Austria
1
South Africa
1
Turkey
1
Lithuania
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic